Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Objective: To evaluate sexual functions of patients with erectile dysfunction (ED) and their female partners.
Methods: A total of 90 consecutive ED patients who received different ED therapies and their partners and 90 consecutive controls and their partners were divided into four groups. All participants were evaluated by the 15-item international index of erectile function and the Arabic version of female sexual function index (Ar-FSFI).
Results: All ED patients who received sildenafil demonstrated significant improvements of their erectile function compared to baseline. Their partners did not demonstrate improvements in frequency of pain during vaginal penetration (3.86 ± 0.58, 3.93 ± 0.45, = 0.477), confidence of becoming aroused (3.86 ± 0.58, 3.93 ± 0.45, 0.477), frequency of satisfaction with arousal (3.07 ± 0.37, 3.03 ± 0.49, 0.712), and maintenance of lubrication (4.37 ± 0.49, 4.23 ± 0.73, 0.354). All ED patients who received quadmix demonstrated significant improvements of their erectile function compared to baseline. Their partners did not demonstrate improvements in desire level (2.6 ± 0.67, 2.63 ± 0.85, = 0.869) and lubrication maintenance (3.53 ± 0.82, 3.47 ± 0.82, = 0.423). Finally, All ED patients who underwent semi rigid penile implant demonstrated significant improvements of their erectile function compared to baseline. Their female partners demonstrated significant improvements in all items of FSFI-19 compared to baseline except the frequency of pain during vaginal penetration (3.86 ± 0.58, 3.93 ± 0.45, = 0.477), confidence of becoming aroused (3.86 ± 0.58, 3.93 ± 0.45, = 0.477), frequency of satisfaction with arousal (3.07 ± 0.37, 3.03 ± 0.49, = 0.712), and maintenance of lubrication (4.37 ± 0.49, 4.23 ± 0.73, = 0.354).
Conclusions: Sexual functions of ED males significantly improved after ED therapies. Nevertheless, some sexual functions of their partners were not positively impacted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/03915603221080290 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!